GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexigen Therapeutics Inc (FRA:JXS1) » Definitions » FCF Yield %

Orexigen Therapeutics (FRA:JXS1) FCF Yield % : -293,142.00 (As of May. 05, 2024)


View and export this data going back to . Start your Free Trial

What is Orexigen Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Orexigen Therapeutics's Trailing 12-Month Free Cash Flow is €0.00 Mil, and Market Cap is €0.02 Mil. Therefore, Orexigen Therapeutics's FCF Yield % for today is -293,142.00%.

The historical rank and industry rank for Orexigen Therapeutics's FCF Yield % or its related term are showing as below:

FRA:JXS1' s FCF Yield % Range Over the Past 10 Years
Min: -94929.4   Med: -21.1   Max: 22.78
Current: -293142


During the past 13 years, the highest FCF Yield % of Orexigen Therapeutics was 22.78%. The lowest was -94929.40%. And the median was -21.10%.

FRA:JXS1's FCF Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.62 vs FRA:JXS1: -293142.00

Orexigen Therapeutics's FCF Margin % for the quarter that ended in Sep. 2017 was -86.13%.


Orexigen Therapeutics FCF Yield % Historical Data

The historical data trend for Orexigen Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexigen Therapeutics FCF Yield % Chart

Orexigen Therapeutics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.11 -12.13 3.57 -21.09 -698.96

Orexigen Therapeutics Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Apr18
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -593.16 -369.04 -367.04 -203.64 -

Competitive Comparison of Orexigen Therapeutics's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Orexigen Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orexigen Therapeutics's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexigen Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Orexigen Therapeutics's FCF Yield % falls into.



Orexigen Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Orexigen Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2016 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-164.523 / 23.5382
=-698.96%

Orexigen Therapeutics's annualized FCF Yield % for the quarter that ended in Sep. 2017 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-13.66 * 4 / 26.832
=-203.64%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orexigen Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Orexigen Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Orexigen Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orexigen Therapeutics (FRA:JXS1) Business Description

Traded in Other Exchanges
N/A
Address
3344 North Torrey Pines Court, Suite 200, La Jolla, CA, USA, 92037
Orexigen is an emerging pharmaceutical company, focusing on developing neuroscience drugs. The company screens older drugs seeking synergistic actions. The company's most advanced drug candidates target obesity.

Orexigen Therapeutics (FRA:JXS1) Headlines

No Headlines